Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU Accelerated Assessment Tracker

Aug 18 2020

• By Maureen Kenny

Related Content

Eiger's Lonafarnib Loses EU Fast-Track Review Status

Aug 13 2020

Bluebird Seeks EU Fast-Track Review For Lenti-D Gene Therapy

Jul 23 2020

Speedy EU Review For AZ/DS's Enhertu; Cheer Too For BMS/bluebird, Celgene And Rhythm

Jun 29 2020

Vertex's Triple CF Combo Gets EU Approval Nod; Rejection For Daiichi Sankyo

Jun 26 2020

ViiV’s Fostemsavir Loses EU Fast-Track Status

Jun 24 2020

Sanofi, Regeneron Seek Fast-Track Reviews From EMA

Jun 23 2020

Roche Seeks Speedy EMA Review For SMA Drug Risdiplam

May 28 2020

Roche’s Evrysdi Approved For SMA, Priced Below Competitors

Aug 08 2020

Related Companies

AstraZeneca PLC

Daiichi Sankyo Co., Ltd.

BioCryst Pharmaceuticals, Inc.

GSK plc

Eiger BioPharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Rhythm Pharmaceuticals, Inc.

Roche Holding AG

PTC Therapeutics, Inc.

Additional Topics

Europe Drug Review Regulation BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window